Physician

Shashinath Katharaghatta Chandrahasegowda, MD

According to 2025 Medicare claims, Shashinath Chandrahasegowda, MD (NPI: 1235333956) practices gastroenterology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is GASTROINTESTINAL CLINIC OF QUAD CITIES, P.C. (NPI: 1942380605; TIN: 421168366) and primary practice location at 61265-6867. Chandrahasegowda is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), participating under the MSSP model.

Chandrahasegowda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 4,242 HCPCS/CPT codes, and received $166,000 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,198 prescription claims across 528 beneficiaries totaling $446,953 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2017 DME data shows 36 claims. Open Payments data shows 48 records totaling $851. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $218,715 and ending at $166,000. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	897	1,938	$218,715
2016	633	1,277	$130,333
2017	619	1,733	$159,408
2018	686	1,737	$143,257
2019	592	1,543	$130,860
2020	506	1,069	$92,776
2021	562	1,239	$123,023
2022	487	1,880	$113,586
2023	474	3,926	$150,517
2024	475	4,242	$166,000

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	416	2,170	$1,056,044
2016	348	2,017	$511,435
2017	356	1,696	$546,675
2018	331	1,527	$432,420
2019	325	1,507	$330,580
2020	380	1,832	$412,677
2021	463	2,186	$521,919
2022	482	2,320	$486,670
2023	490	2,225	$533,568
2024	528	2,198	$446,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$140
2016	N/R	38	$1,372
2017	N/R	36	$2,058
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	121	123	$194
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	84	84	$118
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	120	129	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	171	232	$64
88305	Pathology examination of tissue using a microscope, intermediate complexity	211	491	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	17	700	$173,809
Linzess	Linaclotide	127	4,651	$84,581
Xifaxan	Rifaximin	20	600	$63,165
Mesalamine	Mesalamine	51	2,539	$18,871
Creon	Lipase/Protease/Amylase	14	418	$14,705

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$851	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shashinath Katharaghatta Chandrahasegowda, MD?

Tedicare shows public-source Medicare data for Shashinath Katharaghatta Chandrahasegowda, MD (NPI 1235333956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shashinath Katharaghatta Chandrahasegowda, MD have ACO affiliation data?

Shashinath Katharaghatta Chandrahasegowda, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799).

What billing organization is linked to Shashinath Katharaghatta Chandrahasegowda, MD?

Shashinath Katharaghatta Chandrahasegowda, MD is linked to GASTROINTESTINAL CLINIC OF QUAD CITIES, P.C. (billing NPI 1942380605) in the available physician profile data.

Does Shashinath Katharaghatta Chandrahasegowda, MD have Open Payments data?

Shashinath Katharaghatta Chandrahasegowda, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.